查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1552870

神经诊断市场规模、份额、趋势分析报告：按技术、最终用途、地区、细分市场预测，2024-2030 年

Neurodiagnostics Market Size, Share & Trends Analysis Report By Technology (Neuroimaging Technologies, In Vitro Diagnostics, Neuroinformatics), By End Use (Hospitals & Clinics), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格
简介目录

神经诊断市场成长与趋势：

Grand View Research, Inc.最新报告显示，到2030年，全球神经诊断市场规模预计将达到229.9亿美元，2024年至2030年复合年增长率为3.8%。

推动市场成长的主要因素是由于人口变化和对其管理意识的提高而导致神经系统疾病盛行率的增加。此外，持续的技术改进加上对新型诊断技术日益增长的偏好将进一步刺激市场。神经系统疾病给社会和政府带来了极其沉重的经济负担，全球整体约有 10 亿人遭受痛苦。

在神经影像技术中，电脑断层扫描占据最大的市场占有率，其次是磁振造影造影（MRI）。电脑断层扫描 (CT) 使用电离辐射来创建影像，而 MRI 使用磁场中的无线电波。神经影像技术用于检测脑损伤、脑区域发育畸形以及可能导致中风和癫痫的血管异常。

生物标记在神经系统疾病的体外诊断中发挥重要作用，其开发旨在利用神经系统资讯对疾病进行早期诊断。生物标誌物不可商业购买，其使用仅限于临床研究环境。例如， Tau蛋白的 ELISA 检测可用于阿兹海默症的临床研究。此外，神经资讯学是研究神经科学和资讯科技的领域。这种整合使得以资料库的形式储存神经资料成为可能。预计神经资讯学市场在预测期内将以第二高的成长率成长。

神经诊断市场报告亮点

  • 由于预期寿命的延长，世界各地的老龄化人口正在增加。阿兹海默症和帕金森氏症等与老化相关的神经系统疾病的盛行率正在增加。这些疾病的诊断包括神经影像学、体外诊断和神经资讯学。
  • CT 和 MRI 是全世界最常使用的诊断影像技术，主要用于检测脑部异常。
  • 神经生物标记在为诊断研究提供方向方面前景广阔。目前，市场上还没有商业化的生物标誌物，但正在进行广泛的临床研究以寻找生物标记的完美组合。
  • 2023年，北美占据主要市场占有率约35.8%，并将在预测期内保持领先地位。同时，亚太地区在预测期内的复合年增长率将高达 4.5%。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章神经诊断市场变数、趋势与范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 神经诊断市场分析工具
    • 波特的分析
    • PESTEL分析

第四章神经诊断市场：技术估计与趋势分析

  • 细分仪表板
  • 神经诊断市场：2023 年和 2030 年技术变化分析
  • 神经影像技术
  • 体外诊断
  • 资讯科学

第五章神经诊断市场：最终用途的估计和趋势分析

  • 细分仪表板
  • 神经诊断市场：最终用途变异分析，2023 年和 2030 年
  • 医院和诊所
  • 诊断实验室
  • 形像中心市场
  • 其他的

第六章 神经诊断市场：区域估计与趋势分析

  • 2023 年及 2030 年神经诊断市场占有率（按地区）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 科威特

第七章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • Canon Medical Systems Corporation
    • Siemens Healthineers AG
    • Koninklijke Philips NV
    • Thermo Fisher Scientific, Inc.
    • FUJIFILM Corporation
    • Natus Medical Incorporated（Natus）
    • Lifelines Neuro
    • Advanced Brain Monitoring, Inc.
    • NIHON KOHDEN CORPORATION.
    • F. Hoffmann-La Roche Ltd
    • GE HealthCare.
    • Mitsar Co. LTD.
简介目录
Product Code: GVR-1-68038-277-8

Neurodiagnostics Market Growth & Trends:

The global neurodiagnostics market size is expected to reach USD 22.99 billion by 2030 ,registering a CAGR of 3.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. Key factors driving the market growth include increasing prevalence of neurological diseases due to demographic changes and growing awareness of their management. In addition, consistent technological modifications coupled with increased preference for novel diagnostic technologies will further fuel the market. The economic burden of neurological diseases is extremely high on society and governments with around 1 billion people suffering globally.

Among all the neuroimaging techniques, computed tomography has the largest market share followed by Magnetic Resonance Imaging (MRI). Computed Tomography (CT) uses ionized radiations for the purpose of creating images, whereas MRI uses radio waves in a magnetic field. Neuroimaging techniques are used to detect brain injuries, developmental malformations in the brain area, vascular irregularities that may lead to stroke, epilepsy, etc.

Biomarkers are an important part of in vitro diagnostics for neurological disorders as their development is targeted at the early disease diagnosis with information about the nervous system. Although biomarkers are not commercially available in the market, their use is confined to clinical research settings. For instance, ELISA tests for Tau protein are available in clinical studies of Alzheimer's disease. In addition, neuroinformatics is a field that studies neuroscience and information technology. This integration allows the storage of neurological data in the form of databases. The neuroinformatics market is expected to grow at the second-highest growth rate during the forecast period.

Neurodiagnostics Market Report Highlights:

  • Increased life expectancy has resulted in an increased geriatric population across the globe. The prevalence of aging-related neurological diseases such as Alzheimer's disease and Parkinson's disease is on the rise. The diagnosis of these diseases includes neuroimaging, in vitro diagnosis, and neuroinformatics.
  • CT and MRI are the most commonly used imaging techniques across the globe, which are mainly used to detect brain abnormalities.
  • Neurological biomarkers are extremely promising as they provide a direction to the diagnostic studies. Although currently, no commercial biomarker is available in the market, extensive clinical research is happening to find out the perfect combinations of the biomarkers.
  • North America held the major market share of around 35.8% in 2023 and will retain its top position during the forecast period. On the other hand, Asia Pacific will exhibit the highest CAGR of 4.5% over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Neurodiagnostics Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Neurodiagnostics Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Neurodiagnostics Market: Technology Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Neurodiagnostics Market: Technology Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Neuroimaging Technologies
    • 4.3.1. Neuroimaging Technologies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Computed Tomography (CT)
      • 4.3.2.1. Computed Tomography (CT) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Magnetic Resonance Imaging (MRI)
      • 4.3.3.1. Magnetic Resonance Imaging (MRI) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.4. Nuclear Medicine Imaging (PET, SPECT)
      • 4.3.4.1. Nuclear Medicine Imaging (PET, SPECT) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.5. Near infrared spectroscopic imaging (NIRS)
      • 4.3.5.1. Near infrared spectroscopic imaging (NIRS) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.6. Electro-encephalography (EEG)
      • 4.3.6.1. Electro-encephalography (EEG) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.7. Magneto-encephalography (MEG)
      • 4.3.7.1. Magneto-encephalography (MEG) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.8. Voxel based morphometry (VBM)
      • 4.3.8.1. Voxel based morphometry (VBM) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. In Vitro Diagnostics
    • 4.4.1. In Vitro Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Neuroinformatics
    • 4.5.1. Neuroinformatics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Neurodiagnostics Market: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Neurodiagnostics Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Hospitals and Clinics
    • 5.3.1. Hospitals and Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Diagnostic Laboratories
    • 5.4.1. Diagnostic Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Imaging Centers Market
    • 5.5.1. Imaging Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Neurodiagnostics Market: Regional Estimates & Trend Analysis

  • 6.1. Neurodiagnostics Market Share, By Region, 2023 & 2030 (USD Million)
  • 6.2. North America
    • 6.2.1. North America Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Norway Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. China
      • 6.4.2.1. China Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Japan
      • 6.4.3.1. Japan Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. South Korea
      • 6.4.5.1. South Korea Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. Australia
      • 6.4.6.1. Australia Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Saudi Arabia
      • 6.6.2.1. Saudi Arabia Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. UAE
      • 6.6.3.1. UAE Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. South Africa
      • 6.6.4.1. South Africa Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. Canon Medical Systems Corporation
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. Siemens Healthineers AG
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. Koninklijke Philips N.V.
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. Thermo Fisher Scientific, Inc.
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. FUJIFILM Corporation
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. Natus Medical Incorporated (Natus)
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. Lifelines Neuro
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. Advanced Brain Monitoring, Inc.
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. NIHON KOHDEN CORPORATION.
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives
    • 7.4.10. F. Hoffmann-La Roche Ltd
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Recent Developments/ Strategic Initiatives
    • 7.4.11. GE HealthCare.
      • 7.4.11.1. Participant's Overview
      • 7.4.11.2. Financial Performance
      • 7.4.11.3. Product Benchmarking
      • 7.4.11.4. Recent Developments/ Strategic Initiatives
    • 7.4.12. Mitsar Co. LTD.
      • 7.4.12.1. Participant's Overview
      • 7.4.12.2. Financial Performance
      • 7.4.12.3. Product Benchmarking
      • 7.4.12.4. Recent Developments/ Strategic Initiatives